enbucrilate has been researched along with Benign Neoplasms, Brain in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Aghaz, F; Arkan, E; Bakhtiari, M; Khazaei, M; Vaisi-Raygani, A | 1 |
| Ahmadi, Z; Akbarzadeh Khiyavi, A; Chiani, M; Ehsanbakhsh, H; Mazloomi, E; Nemati, M; Rezaeidian, J; Sadeghi, V; Toofani Milani, A | 1 |
| Chang, FC; Guo, WY; Lirng, JF; Lu, YH; Luo, CB; Wang, HH; Wong, TT; Wu, HM | 1 |
| Akbarzadeh, A; Alavi, SE; Ebrahimi Shahmabadi, H; Eslamifar, A; Koohi Moftakhari Esfahani, M; Mohammadi Anaraki, G; Movahedi, F | 1 |
| Alaraj, A; Aletich, VA; Charbel, FT; Dashti, R; Goodin, S; Mehta, NK | 1 |
| Ashour, R; Aziz-Sultan, A | 1 |
| Hwang, C; Hwang, SM; Lee, DH; Lim, OK; Park, S | 1 |
| Ambruosi, A; Begley, DJ; Gelperina, SE; Khalansky, AS; Kreuter, J; Yamamoto, H | 1 |
| Ambruosi, A; Gelperina, S; Khalansky, A; Kreuter, J; Tanski, S; Theisen, A | 1 |
| Requejo, F; Schumacher, M; van Velthoven, V | 1 |
| Bobruskin, AI; Gelperina, SE; Khalansky, AS; Kreuter, J; Severin, SE; Skidan, IN; Smirnova, ZS; Turowski, B; Zanella, FE | 1 |
1 review(s) available for enbucrilate and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Preoperative tumor embolization.
Topics: Brain Neoplasms; Drug Combinations; Embolization, Therapeutic; Enbucrilate; Endovascular Procedures; Humans; Neoplasms, Vascular Tissue; Paraganglioma, Extra-Adrenal; Polyvinyls; Preoperative Care; Spinal Neoplasms; Tantalum | 2014 |
10 other study(ies) available for enbucrilate and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Anticancer Effect of Cisplatin-Loaded Poly (Butylcyanoacrylate) Nanoparticles on A172 Brain Cancer Cells Line.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cisplatin; Drug Carriers; Drug Delivery Systems; Enbucrilate; Humans; Nanoparticles; Polymers | 2020 |
Anticancer Effect of Cisplatin-Loaded Poly (Butylcyanoacrylate) Nanoparticles on A172 Brain Cancer Cells Line
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cisplatin; Drug Carriers; Drug Delivery Systems; Enbucrilate; Humans; Nanoparticles; Polymers | 2019 |
Preoperative embolization of hypervascular pediatric brain tumors: evaluation of technical safety and outcome.
Topics: Acrylic Resins; Adolescent; Blood Loss, Surgical; Brain Neoplasms; Child; Embolization, Therapeutic; Enbucrilate; Female; Gelatin; Humans; Infant; Male; Neurosurgical Procedures; Paresis; Postoperative Complications; Preoperative Period; Retrospective Studies; Treatment Outcome | 2013 |
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cisplatin; Drug Carriers; Drug Stability; Enbucrilate; Glioblastoma; Male; Nanoparticles; Rats; Rats, Wistar; Solubility | 2014 |
Augmentation of N-butyl cyanoacrylate embolization of cranial, head, and neck tumors by simultaneous infusion of 5% dextrose solution.
Topics: Aged, 80 and over; Brain Neoplasms; Embolization, Therapeutic; Enbucrilate; Glucose; Head and Neck Neoplasms; Humans; Middle Aged; Treatment Outcome; Vascular Access Devices | 2015 |
Compliant neurovascular balloon catheters may not be compatible with liquid embolic materials: intraprocedural rupture of the protecting balloon during tumor embolization using n-butyl cyanoacrylate and lipiodol mixture.
Topics: Antineoplastic Agents; Balloon Occlusion; Brain Neoplasms; Catheters; Chemoembolization, Therapeutic; Dimethyl Sulfoxide; Enbucrilate; Equipment Failure; Ethiodized Oil; Hemangioma; Humans; In Vitro Techniques; Male; Middle Aged; Polyvinyls; Solvents | 2015 |
Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.
Topics: Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Doxorubicin; Enbucrilate; Excipients; Glioblastoma; Injections, Intravenous; Male; Nanostructures; Neoplasm Transplantation; Particle Size; Polysorbates; Rats; Rats, Wistar; Suspensions; Tissue Distribution | 2006 |
Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.
Topics: Animals; Antibiotics, Antineoplastic; Brain Neoplasms; Delayed-Action Preparations; Disease Models, Animal; Doxorubicin; Drug Compounding; Enbucrilate; Glioblastoma; Hydrogen-Ion Concentration; Injections, Intravenous; Kaplan-Meier Estimate; Male; Nanoparticles; Rats; Rats, Wistar; Surface-Active Agents | 2006 |
Coating the wall of an injured intracranial carotid artery during tumor removal with n-butyl-2-cyanoacrylate: technical case report.
Topics: Brain Neoplasms; Carotid Artery Injuries; Child; Enbucrilate; Humans; Male; Neurosurgical Procedures; Tissue Adhesives; Treatment Outcome | 2006 |
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.
Topics: Animals; Antineoplastic Agents; Body Weight; Brain Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Enbucrilate; Excipients; Glioblastoma; Longevity; Maximum Tolerated Dose; Nanotechnology; Neoplasm Transplantation; Organ Size; Polysorbates; Rats; Rats, Wistar; Tumor Cells, Cultured | 2002 |